Listen "Cybin"
Episode Synopsis
Cybin (OTCQB: CLXPF) is a life sciences company at the forefront of the revolution in mental health therapeutics and is developing a new class of psychedelic medicines and treatment protocols, with the goal of becoming the leader in psychedelic therapeutics for mental well-being. CEO Douglas Drysdale joins us to discuss the company's unique and non-traditional approach to treat mental and neurological disorders.
View Podcast Transcript for Cybin Inc
More episodes of the podcast OTCQB Podcast
Cytta Corp.
12/01/2026
DarkPulse, Inc.
05/01/2026
Q2 Metals Corp.
08/12/2025
Zoomcar Holdings, Inc.
01/12/2025
Scorpio Gold Corp.
24/11/2025
Stuhini Exploration Ltd.
17/11/2025
Dotz Nano Ltd.
10/11/2025
District Metals Corp.
03/11/2025
Banyan Gold Corp.
27/10/2025
Brixton Metals Corp.
20/10/2025
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.